This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Taho Pharmaceuticals Ltd., Transwell Biotech Co., Ltd.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New Taipei, TW (2018 - 2020)
- Taoyuan, TW (2020 - 2022)
Company Filing History:
Years Active: 2018-2022
Title: The Innovations of Taijung Wu
Introduction
Taijung Wu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in the development of transdermal delivery systems. With a total of 5 patents to his name, Wu's work focuses on improving treatment options for neurological disorders.
Latest Patents
One of Wu's latest patents is the "Pramipexole transdermal delivery system and uses thereof." This invention features a pramipexole transdermal patch designed for the treatment of neurological disorders, including Parkinson's disease. The patch can be administered daily and comprises a drug-containing layer with pramipexole or a pharmaceutically acceptable salt at a concentration of 2% to about 15% by weight. Additionally, it includes at least two acrylic polymers, which may contain carboxyl and/or hydroxyl functional groups. The patch may also incorporate two or more permeation enhancers, achieving a combined pramipexole solubility of greater than 50 mg/mL.
Career Highlights
Throughout his career, Taijung Wu has worked with various companies, including Taho Pharmaceuticals Ltd. and Transwell Biotech Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Wu has collaborated with several professionals in his field, including Catherine Lee and Shen-Yung Kao. These partnerships have facilitated the exchange of ideas and advancements in his research.
Conclusion
Taijung Wu's contributions to the field of medical technology, particularly through his innovative pramipexole transdermal delivery system, highlight his commitment to improving treatment options for patients with neurological disorders. His work continues to inspire advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile